Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide Dose Response in Japanese Postmenopausal Osteoporosis
NCT00191867Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of teriparatide in osteoporosis, sponsored by Eli Lilly and Company. Started Feb 2005; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00191867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191867.